SEC Form 4 · accession 0001214659-26-011121
Alzamend Neuro, Inc. · ALZN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Milton C Ault III
Director
Period of report
Aug 26, 2026
Accepted (ET)
Aug 31, 2026 · 6:05 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001677077
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 26, 2026 | S | 2,000 | $1.5581 | D | 0 | D | |
| Common StockF3 | holding | — | — | — | 116,648 | I | By Ault Lending, LLC | |
| Common StockF4 | holding | — | — | — | 11,068 | I | By Ault Life Sciences, Inc. | |
| Common StockF5 | holding | — | — | — | 61 | I | By Ault Life Sciences Fund, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of these shares is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.
- F2The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $1.5581. The range of sale prices on the transaction date was $1.55 to $1.5619 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- F3Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Capital Group, Inc. ("ACG"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
- F4Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- F5Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
Remarks
Mr. Ault, the Executive Chairman of HSD, which wholly owns ACG, which in turn wholly owns Ault Lending, is a director of the Issuer. For purposes of Section 16 of the Exchange Act, each of HSD, ACG and Ault Lending may be deemed a director by deputization by virtue of their respective representation on the Board of Directors of the Issuer.